Tokyo

London

New York

finscreener facebook fan page

finscreener twitter page

finscreener linkedin page

TRACON Pharmaceuticals, Inc.

TRADE

NASDAQ: TCONHealthcare / Biotechnology / USA
1.6100.00Vol 173 5151Y Perf -46.89%
Oct 17th, 2018 16:00
BID1.61 ASK1.63
Open1.60 Previous Close1.61
Pre-Market- After-Trading1.61
 - -%  - -%
Target Price
5.13 
Analyst Rating
Moderate Buy 2.00
Potencial %
218.63 
Finscreener Ranking
 —    -
Insiders Trans % 3/6/12M
-/-/100 
Value Ranking
 —    -
Insiders Value % 3/6/12M
-/-/100 
Growth Ranking
★+     42.31
Insiders Shares Cnt. % 3/6/12M
-/-/100 
Income Ranking
 —    -
Market Cap (mil)48 
Earnings Rating
Buy
Price Range Ratio 52wk %
1.00 
Earnings Date
6th Nov 2018

Today's Price Range

1.591.70

 

52wk Range

1.593.60

Summary:

Sell

Technical Indicators: Sell
Moving Averages: Strong Sell
Performance
1 Month
-28.44%
3 Months
-39.25%
6 Months
-43.51%
1 Year
-46.89%
3 Years
-83.70%
5 Years
-

Quotes

Name / TickerPriceChg.Chg.%
TCON1.610.00000.00
AAPL221.19-0.9600-0.43
GOOG1 115.69-5.5900-0.50
MSFT110.71-0.2900-0.26
XOM81.500.30000.37
WFC54.460.73001.36
JNJ139.462.90002.12
FB159.420.64000.40
GE12.190.09000.74
JPM109.831.21001.11
Financial StrengthValueIndustryS&P 500US Markets
Quick Ratio 4.70
Current Ratio 4.80
Long Term Debt to Total Capital 0.14
Total Debt to Equity 0.17
Interest Coverage -93.90
Leverage Ratio 1.60
ProfitabilityValueIndustryS&P 500US Markets
Gross Margin-
EBIT Margin-218.00
EBITDA Margin-217.70
Pre-tax Profit Margin-
Profit Margin-
ValuationValueIndustryS&P 500US Markets
PE Ratio -
PB Ratio 1.45
PS Ratios 17.90
Price to Cash Flow 74.30
Price to Free Cash Flow -2.90
Cash Flow Per Share -0.84
Price to Tangible Book1.45
Book Value per Share1.24
Enterprise Value (in ths.)6 605
Management EffectivenessValueIndustryS&P 500US Markets
Return on Equity (5Y Avg)1 149.39
ROE last 12 Months -86.04
Return on Assets (5Y Avg) -39.98
ROA last 12 Months -53.09
Return on Capital (5Y Avg) -
ROC last 12 Months -70.64
Return on invested Capital Q -21.22
Return on invested Capital Y-63.44
Assets Turnover0.10
Receivables Turnover-
RevenueValueIndustryS&P 500US Markets
Revenue LTM (in ths.)3 000
Revenue per Share 0.10
Revenue Growth 3 Years -12.78
Revenue Growth 5 Years -
DividendsValueIndustryS&P 500US Markets
Dividend Yield -
Dividend Rate -
Dividend Growth 3 Years-
Dividend Growth 5 Years-

Earnings HistoryEstimateReportedSurprise %
Q02 2018-0.30-0.33-10.00
Q01 2018-0.33-0.46-39.39
Q04 2017-0.45-0.3717.78
Q03 2017-0.250.07128.00
Q02 2017-0.53-0.4024.53
Q01 2017-0.47-0.446.38
Q04 2016-0.45-0.450.00
Q03 2016-0.58-0.4817.24
Earnings Per EndEstimateRevision %Trend
9/2018 QR-0.273.57Positive
12/2018 QR-0.238.00Positive
12/2018 FY-1.230.81Positive
12/2019 FY-0.342.86Positive
Next Report Date6th Nov 2018
Estimated EPS Next Report-0.27
Estimates Count2
EPS Growth Next 5 Years %-
Volume Overview
Volume173 515
Shares Outstanding (in ths.)29 840
Trades Count351
Dollar Volume228 930
Avg. Volume148 553
Avg. Weekly Volume96 448
Avg. Monthly Volume94 182
Avg. Quarterly Volume92 547

Bearish or Bullish?
WeekMonthThree MonthsSix Months

Bearish Bullish

50%50%

Bearish Bullish

54%46%

Bearish Bullish

52%48%

Bearish Bullish

64%36%

Analyst RatingsCurrent1 M ago3 M ago
Strong Buy
1 (50.00 %)
1 (50.00 %)
1 (50.00 %)
Moderate Buy
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Hold
1 (50.00 %)
1 (50.00 %)
1 (50.00 %)
Moderate Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Strong Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
RatingModerate Buy
2.00
Moderate Buy
2.00
Moderate Buy
2.00

There are no comments yet.

News

x